| |
| |
|
| Insider
Information: |
Kazam Joshoa A |
| Relationship: |
Former Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
2,457,077 |
|
|
Indirect Shares
|
613,318 |
|
|
| Direct
Value |
$7,012,890 |
|
|
|
Indirect Value
|
$5,691 |
|
|
| Total
Shares |
3,070,395 |
|
|
| Total
Value |
$7,018,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
TG Therapeutics Inc |
TGTX |
Director |
2005-04-01 |
492,852 |
2005-04-01 |
0 |
Premium* |
|
|
Velcera Inc |
VLCR |
Director |
2007-02-27 |
333,838 |
2007-02-27 |
141,768 |
Premium* |
|
|
Capricor Therapeutics |
CAPR |
Director |
2015-01-21 |
38,084 |
2015-01-21 |
18,896 |
Premium* |
|
|
Arno therapeutics Inc |
ARNI |
Director |
2008-06-03 |
1,129,759 |
2008-06-03 |
452,654 |
Premium* |
|
|
Kite Pharma, Inc. |
KITE |
Director |
2017-10-03 |
0 |
2017-10-03 |
0 |
Premium* |
|
|
Allogene Therapeutics, Inc. |
ALLO |
|
2022-06-15 |
303,063 |
2018-10-15 |
0 |
Premium* |
|
|
Target Hospitality Corp |
TH |
Director |
2019-03-05 |
10,000 |
2019-03-01 |
0 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
Director |
2022-03-07 |
94,481 |
|
0 |
Premium* |
|
|
Tishman Speyer Innovation Corp. Ii |
TSIB |
Director |
2021-02-12 |
25,000 |
2021-02-12 |
0 |
Premium* |
|
|
Ts Innovation Acquisitions Corp. |
TSIAU |
Former Director |
2021-06-04 |
30,000 |
2021-06-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
44,178 |
303,063 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
Director |
– • – |
2022-03-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
211,000 |
94,481 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
Director |
– • – |
2022-03-07 |
4 |
GA |
$0.00 |
$0 |
D/D |
211,000 |
305,481 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2022-03-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
412,618 |
258,885 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
412,618 |
671,503 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2022-01-12 |
4 |
B |
$12.60 |
$189,000 |
D/D |
15,000 |
258,885 |
0.01 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2021-06-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
500,000 |
243,885 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
16,498 |
743,885 |
0 |
- |
|
| TSIAU |
Ts Innovation Acquisition... |
Former Director |
– – – |
2021-06-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| TSIB |
Tishman Speyer Innovation... |
Director |
– • – |
2021-02-12 |
4 |
B |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
2.31 |
- |
|
| KRON |
Kronos Bio, Inc. |
Director |
– • – |
2020-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
92,371 |
94,481 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
Director |
– • – |
2020-10-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,110 |
|
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
9,969 |
1,033,305 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2020-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
8,039 |
1,023,336 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2020-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,217 |
1,015,297 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2019-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,217 |
1,445,486 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2019-09-23 |
4 |
A |
$0.00 |
$0 |
D/D |
8,217 |
1,437,269 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2019-09-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,217 |
1,429,052 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Director |
– • – |
2019-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
8,217 |
1,420,835 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Director |
– • – |
2019-07-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,590 |
1,412,618 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Director |
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
16,377 |
1,407,028 |
0 |
- |
|
| TH |
Target Hospitality Corp |
Director |
– • – |
2019-03-05 |
4 |
B |
$10.20 |
$51,000 |
D/D |
5,000 |
10,000 |
2.39 |
- |
|
| TH |
Target Hospitality Corp |
Director |
– • – |
2019-03-01 |
4 |
B |
$10.13 |
$50,650 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Director |
– • – |
2018-10-15 |
4 |
A |
$0.00 |
$0 |
D/D |
18,716 |
1,390,651 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,807) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
